In our latest monthly catch-up with top private investor John Rosier gives us his latest portfolio update, and how June has brought respite after a May to forget. Includes a look at the commodities balancing act between economic weakness and long-term supply deficits, the best ways to invest in healthcare, and assessing the AI threat.
You can read John’s Investment Chronicle in full by visiting https://www.jicuk.com/jic-portfolio and signing up for a two-week free trial.
01.08 Why the long-term case for commodities remains intact despite recent share price weakness across the sector as a result of current investor worries about the threat of recession.
3:27 The potential impact of the need for capital investment in new production on the current high cashflows and dividends of miners.
04:58 The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May.
07.52 Bioventix (BVXP) and investing in healthcare via the picks and shovels approach.
11:36 The importance of assessing the impact of AI on portfolio companies, positively and negatively, and the case for selling CentralNic (CNIC).
13:50 The rationale behind new purchases including IG Group (IGG) and “quality compounder” RS Group (RS1), formerly Electrocomponents.
14:52 Translation specialist RWS (RWS) as an example of the difficulties in assessing AI’s impact.
18:20 Why John’s bought “boring” oversold Unilever (ULVR) on the back of recent price weakness.
21:55 The tailwinds that have taken the portfolio back above £600k, including Me Group’s (MEGP) ongoing transformation into a cash generating machine.
23:50 Shoe Zone (SHOE) and its continuing earnings upgrade cycle and further buybacks.
24:50How the huge drop in the cost of shipping has helped Shoe Zone, and the potential read-across to IG Design (IGR).
26.45 Serica Energy’s (SQZ) bounce back from its March low point.